It is generally known that OS can not only activate the transcription factor NF-κB that targets at inflammation, cell proliferation, cell migration, and apoptosis, but also lead to DNA damage via vascular tissue damage, protein structure and function damage, genomic damage, through both of which compensatory cellular proliferation is induced and BPH ultimately occurs [27]. Here, NFKB1 is linked to benign prostatic hyperplasia.